May 10, 2025
See all results
Balancing the Risks and Benefits of Medications
Newsletter
DONATE
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
The PPI Debate: Could Common Heartburn Drugs Be Harming Your Brain?
Controlled Drug Classifications: Schedule I, II, III, IV, V
FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More
Are Melatonin Supplements Safe for Kids?
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
VIDEOS
The PPI Debate: Could Common Heartburn Drugs Be Harming Your Brain?
Controlled Drug Classifications: Schedule I, II, III, IV, V
FDA SIDE EFFECTS UPDATE: Baqsimi and Serious Hypersensitivity Reactions, Plus More
Are Melatonin Supplements Safe for Kids?
FDA SIDE EFFECTS UPDATE: Migraine Drugs and High Blood Pressure, Circulation Problems
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
PODCAST
Preventable Illnesses: Lifestyle Choices Over Medication
Childhood Asthma and Obesity: The Road to Resilience
Food As Fuel: Managing Sugar Cravings to Fight Inflammation
Creativity in Veganism, and Discovering Vegan Life Balance
Preventative Senior Fitness, Super-Agers, and Trusting Your Body
INFOGRAPHICS
Login / Signup
Search
Home
Public Health - Government & Society
FDA
Latest
Latest
Oldest
Random
A to Z
FDA
FDA
A New Opioid Deterrent Falls Short For FDA
Suzanne B. Robotti
FDA
FDA Finds Eye Injections Caused Vision Impairment
Alanna McCatty
Quick Hits
Quick Hits: FDA Decisions and FDA Approvals
Alanna McCatty
FDA
Why Sentinel, A FDA Drug Safety Monitoring System, Is Failing
Steven Findlay
FDA Watch
The FDA Calls For Opana’s Removal From The Market
Jonathan Block
FDA
Recent Drug Approval Highlights Less Stringent FDA Criteria
Jonathan Block
FDA Watch
FDA Safe Use Initiative: Safe Only When Taken as Directed
Jonathan Block
Issues Related to Healthcare
Faster FDA Approvals = More Drug Safety Problems
deirdrewyeth
FDA
Can You Trust a New Drug FDA Approved?
Suzanne B. Robotti
FDA
FDA Approves Radicava, First New ALS Drug In More Than 2 Decades
Jonathan Block
FDA Watch
Scott Gottlieb’s Potential Impact on the FDA as Commissioner
Steven Findlay
FDA
How Abuse of the Orphan Drug Act Hurts Patients
Jonathan Block
OTC
FDA Committees Wary of OTC Hangover Remedy
Jonathan Block
FDA
Weighing Risks and Benefits of Opana ER
Suzanne B. Robotti
FDA Watch
Is the 21st Century Cures Act Really Bad Medicine for Patients?
Steven Findlay
FDA
What Happens When The FDA Is Addicted To The Drug Industry?
Jonathan Block
Issues Related to Healthcare
Episode 12: The 21st Century Cures Act
deirdrewyeth
FDA
Prescription Drug Advertising May Soon Come to Twitter
Jonathan Block
FDA
Time For The FDA To Get Tough On Off-Label Drug Promotion
Jonathan Block
E-Cigarette News
FDA Needs to Go Further in Curbing E-Cigarette Use by Teens
Jonathan Block
Load More
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
INFOGRAPHICS
Newsletter
DONATE
Newsletter
JOIN
Start typing to see results or hit ESC to close
FDA
side effects
depression
Opioids
cancer
See all results
Username
Password
Remember Me
Sign In
Lost password?
Create an account
Enter username or email
Cancel